Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 576

1.

Pharmacokinetics of Sublingual Buprenorphine Tablets Following Single and Multiple Doses in Chinese Participants With and Without Opioid Use Disorder.

Dong R, Wang H, Li D, Lang L, Gray F, Liu Y, Laffont CM, Young M, Jiang J, Liu Z, Learned SM.

Drugs R D. 2019 Sep;19(3):255-265. doi: 10.1007/s40268-019-0277-9.

2.

Real-world impact of the high concentration non-avian high molecular weight hyaluronan on pain medication use among osteoarthritis patients.

Chitnis AS, Etter K, Holy CE, Gray FS, Manalac FJ, Bisson B, Bhattacharyya SK.

Curr Med Res Opin. 2019 Apr 1:1-5. doi: 10.1080/03007995.2019.1596670. [Epub ahead of print]

PMID:
30884980
3.

Changing the Apoptosis Pathway through Evolutionary Protein Design.

Shultis D, Mitra P, Huang X, Johnson J, Khattak NA, Gray F, Piper C, Czajka J, Hansen L, Wan B, Chinnaswamy K, Liu L, Wang M, Pan J, Stuckey J, Cierpicki T, Borchers CH, Wang S, Lei M, Zhang Y.

J Mol Biol. 2019 Feb 15;431(4):825-841. doi: 10.1016/j.jmb.2018.12.016. Epub 2019 Jan 6.

PMID:
30625288
4.

Treatment of opioid dependence with buprenorphine/naloxone sublingual tablets: A phase 3 randomized, double-blind, placebo-controlled trial.

Wang X, Jiang H, Zhao M, Li J, Gray F, Sheng L, Li Y, Li X, Ling W, Li W, Hao W.

Asia Pac Psychiatry. 2019 Mar;11(1):e12344. doi: 10.1111/appy.12344. Epub 2018 Nov 20.

PMID:
30460781
5.

The BDA First World War Memorial.

Gray FSS.

Br Dent J. 2018 Nov 9;225(9):892-897. doi: 10.1038/sj.bdj.2018.924.

PMID:
30412551
6.

Anti-IL-7 receptor α monoclonal antibody (GSK2618960) in healthy subjects - a randomized, double-blind, placebo-controlled study.

Ellis J, van Maurik A, Fortunato L, Gisbert S, Chen K, Schwartz A, McHugh S, Want A, Santos Franco S, Oliveira JJ, Price J, Coles A, Brown K, Su D, Craigen JL, Yang J, Brett S, Davis B, Cheriyan J, Kousin-Ezewu O, Gray F, Thompson PW, Fernando D.

Br J Clin Pharmacol. 2019 Feb;85(2):304-315. doi: 10.1111/bcp.13748. Epub 2018 Dec 3.

7.

Insights into the evolutionary conserved regulation of Rio ATPase activity.

Knüppel R, Christensen RH, Gray FC, Esser D, Strauß D, Medenbach J, Siebers B, MacNeill SA, LaRonde N, Ferreira-Cerca S.

Nucleic Acids Res. 2018 Feb 16;46(3):1441-1456. doi: 10.1093/nar/gkx1236.

8.

YY1 controls Eμ-3'RR DNA loop formation and immunoglobulin heavy chain class switch recombination.

Mehra P, Gerasimova T, Basu A, Jha V, Banerjee A, Sindhava V, Gray F, Berry CT, Sen R, Atchison ML.

Blood Adv. 2016 Nov 29;1(1):15-20. doi: 10.1182/bloodadvances.2016000372. No abstract available.

9.

Translational evidence for two distinct patterns of neuroaxonal injury in sepsis: a longitudinal, prospective translational study.

Ehler J, Barrett LK, Taylor V, Groves M, Scaravilli F, Wittstock M, Kolbaske S, Grossmann A, Henschel J, Gloger M, Sharshar T, Chretien F, Gray F, Nöldge-Schomburg G, Singer M, Sauer M, Petzold A.

Crit Care. 2017 Oct 23;21(1):262. doi: 10.1186/s13054-017-1850-7.

10.

Pesticides in essential oils: Occurrence and concentration in organic and conventional orange essential oils from eleven geographical origins.

Fillâtre Y, Gray FX, Roy C.

Anal Chim Acta. 2017 Nov 1;992:55-66. doi: 10.1016/j.aca.2017.08.039. Epub 2017 Sep 4.

PMID:
29054150
11.

RIPK1-dependent apoptosis bypasses pathogen blockade of innate signaling to promote immune defense.

Peterson LW, Philip NH, DeLaney A, Wynosky-Dolfi MA, Asklof K, Gray F, Choa R, Bjanes E, Buza EL, Hu B, Dillon CP, Green DR, Berger SB, Gough PJ, Bertin J, Brodsky IE.

J Exp Med. 2017 Nov 6;214(11):3171-3182. doi: 10.1084/jem.20170347. Epub 2017 Aug 30.

12.

Reply to "Axonal hyperexcitability due to Schwann cell involvement in chronic progressive external ophthalmoplegia".

Guéguen A, Jardel C, Polivka M, Tan SV, Gray F, Vignal C, Lombès A, Gout O, Bostock H.

Clin Neurophysiol. 2017 Oct;128(10):2098. doi: 10.1016/j.clinph.2017.07.407. Epub 2017 Jul 31. No abstract available.

PMID:
28838816
13.

Quantification of human brain PDE4 occupancy by GSK356278: A [11C](R)-rolipram PET study.

van der Aart J, Salinas C, Dimber R, Pampols-Maso S, Weekes AA, Tonkyn J, Gray FA, Passchier J, Gunn RN, Rabiner EA.

J Cereb Blood Flow Metab. 2018 Nov;38(11):2033-2040. doi: 10.1177/0271678X17720868. Epub 2017 Jul 24.

14.

The first dentists sent to the Western Front during the First World War.

Gray FSS.

Br Dent J. 2017 Jun 9;222(11):893-897. doi: 10.1038/sj.bdj.2017.503.

PMID:
28703148
15.

Nerve excitability changes related to muscle weakness in chronic progressive external ophthalmoplegia.

Gueguen A, Jardel C, Polivka M, Tan SV, Gray F, Vignal C, Lombès A, Gout O, Bostock H.

Clin Neurophysiol. 2017 Jul;128(7):1258-1263. doi: 10.1016/j.clinph.2017.04.013. Epub 2017 Apr 26.

PMID:
28535487
16.
17.

BMI1 regulates PRC1 architecture and activity through homo- and hetero-oligomerization.

Gray F, Cho HJ, Shukla S, He S, Harris A, Boytsov B, Jaremko Ł, Jaremko M, Demeler B, Lawlor ER, Grembecka J, Cierpicki T.

Nat Commun. 2016 Nov 9;7:13343. doi: 10.1038/ncomms13343.

18.
19.

A One Health overview, facilitating advances in comparative medicine and translational research.

Stroud C, Dmitriev I, Kashentseva E, Bryan JN, Curiel DT, Rindt H, Reinero C, Henry CJ, Bergman PJ, Mason NJ, Gnanandarajah JS, Engiles JB, Gray F, Laughlin D, Gaurnier-Hausser A, Wallecha A, Huebner M, Paterson Y, O'Connor D, Treml LS, Stannard JP, Cook JL, Jacobs M, Wyckoff GJ, Likins L, Sabbagh U, Skaff A, Guloy AS, Hays HD, LeBlanc AK, Coates JR, Katz ML, Lyons LA, Johnson GC, Johnson GS, O'Brien DP, Duan D, Calvet JP, Gandolfi B, Baron DA, Weiss ML, Webster DA, Karanu FN, Robb EJ, Harman RJ.

Clin Transl Med. 2016 Aug;5(Suppl 1):26. doi: 10.1186/s40169-016-0107-4.

20.

Immunotherapy with a HER2-Targeting Listeria Induces HER2-Specific Immunity and Demonstrates Potential Therapeutic Effects in a Phase I Trial in Canine Osteosarcoma.

Mason NJ, Gnanandarajah JS, Engiles JB, Gray F, Laughlin D, Gaurnier-Hausser A, Wallecha A, Huebner M, Paterson Y.

Clin Cancer Res. 2016 Sep 1;22(17):4380-90. doi: 10.1158/1078-0432.CCR-16-0088. Epub 2016 Mar 18.

21.

A neuropathological study of cerebrovascular abnormalities in a signal transducer and activator of transcription 3-deficient patient.

Chandesris MO, Gray F, Bruneval P, Azarine A, Boddaert N, Oppenheim C, Paraire F, Touzé E, Bonnet D, Hermine O, Lortholary O, Cormier-Daire V, Boutouyrie P, Mallat Z, Fischer A, Picard C.

J Allergy Clin Immunol. 2015 Nov;136(5):1418-21.e1-5. doi: 10.1016/j.jaci.2015.05.021. Epub 2015 Jun 30. No abstract available.

PMID:
26141261
22.

Limb reconstruction with decellularized, non-demineralized bone in a young leporine model.

Pennington EC, Dionigi B, Gray FL, Ahmed A, Brazzo J, Dolinko A, Calderon N, Darrah T, Zurakowski D, Nazarian A, Snyder B, Fauza DO.

Biomed Mater. 2015 Feb 10;10(1):015021. doi: 10.1088/1748-6041/10/1/015021.

PMID:
25668190
23.

A single-blind, pilot randomised trial of a weight management intervention for adults with intellectual disabilities and obesity: study protocol.

Harris L, Melville C, Jones N, Pert C, Boyle S, Murray H, Tobin J, Gray F, Hankey C.

Pilot Feasibility Stud. 2015 Jan 12;1:5. doi: 10.1186/2055-5784-1-5. eCollection 2015.

24.

Increased levels of cerebrospinal fluid JNK3 associated with amyloid pathology: links to cognitive decline.

Gourmaud S, Paquet C, Dumurgier J, Pace C, Bouras C, Gray F, Laplanche JL, Meurs EF, Mouton-Liger F, Hugon J.

J Psychiatry Neurosci. 2015 May;40(3):151-61.

25.

Effect of active Aβ immunotherapy on neurons in human Alzheimer's disease.

Paquet C, Amin J, Mouton-Liger F, Nasser M, Love S, Gray F, Pickering RM, Nicoll JA, Holmes C, Hugon J, Boche D.

J Pathol. 2015 Apr;235(5):721-30. doi: 10.1002/path.4491. Epub 2015 Jan 7.

PMID:
25430817
26.

GSK356278, a potent, selective, brain-penetrant phosphodiesterase 4 inhibitor that demonstrates anxiolytic and cognition-enhancing effects without inducing side effects in preclinical species.

Rutter AR, Poffe A, Cavallini P, Davis TG, Schneck J, Negri M, Vicentini E, Montanari D, Arban R, Gray FA, Davies CH, Wren PB.

J Pharmacol Exp Ther. 2014 Jul;350(1):153-63. doi: 10.1124/jpet.114.214155. Epub 2014 Apr 30.

PMID:
24784567
27.

Primary angiitis of the central nervous system: description of the first fifty-two adults enrolled in the French cohort of patients with primary vasculitis of the central nervous system.

de Boysson H, Zuber M, Naggara O, Neau JP, Gray F, Bousser MG, Crassard I, Touzé E, Couraud PO, Kerschen P, Oppenheim C, Detante O, Faivre A, Gaillard N, Arquizan C, Bienvenu B, Néel A, Guillevin L, Pagnoux C; French Vasculitis Study Group and the French NeuroVascular Society.

Arthritis Rheumatol. 2014 May;66(5):1315-26. doi: 10.1002/art.38340.

28.

Safety, pharmacokinetics, pharmacodynamics, and bioavailability of GSK2018682, a sphingosine-1-phosphate receptor modulator, in healthy volunteers.

Xu J, Gray F, Henderson A, Hicks K, Yang J, Thompson P, Oliver J.

Clin Pharmacol Drug Dev. 2014 May;3(3):170-8. doi: 10.1002/cpdd.98. Epub 2014 Feb 10.

PMID:
27128606
29.

The haloarchaeal MCM proteins: bioinformatic analysis and targeted mutagenesis of the β7-β8 and β9-β10 hairpin loops and conserved zinc binding domain cysteines.

Kristensen TP, Maria Cherian R, Gray FC, MacNeill SA.

Front Microbiol. 2014 Mar 26;5:123. doi: 10.3389/fmicb.2014.00123. eCollection 2014.

30.

Characterising the plasma-target occupancy relationship of the neurokinin antagonist GSK1144814 with PET.

Ridler K, Gunn RN, Searle GE, Barletta J, Passchier J, Dixson L, Hallett WA, Ashworth S, Gray FA, Burgess C, Poggesi I, Bullman JN, Ratti E, Laruelle MA, Rabiner EA.

J Psychopharmacol. 2014 Mar;28(3):244-53. doi: 10.1177/0269881113517953. Epub 2014 Jan 15.

PMID:
24429221
31.

Loss of endoplasmic reticulum calcium pump expression in choroid plexus tumours.

Ait-Ghezali L, Arbabian A, Jeibmann A, Hasselblatt M, Hallaert GG, Van den Broecke C, Gray F, Brouland JP, Varin-Blank N, Papp B.

Neuropathol Appl Neurobiol. 2014 Oct;40(6):726-35. doi: 10.1111/nan.12098.

PMID:
24224513
32.

Arf activation at the Golgi is modulated by feed-forward stimulation of the exchange factor GBF1.

Quilty D, Gray F, Summerfeldt N, Cassel D, Melançon P.

J Cell Sci. 2014 Jan 15;127(Pt 2):354-64. doi: 10.1242/jcs.130591. Epub 2013 Nov 8.

33.

An evolution-based approach to De Novo protein design and case study on Mycobacterium tuberculosis.

Mitra P, Shultis D, Brender JR, Czajka J, Marsh D, Gray F, Cierpicki T, Zhang Y.

PLoS Comput Biol. 2013 Oct;9(10):e1003298. doi: 10.1371/journal.pcbi.1003298. Epub 2013 Oct 24.

34.

Predictive value of the Pediatric Ulcerative Colitis Activity Index in the surgical management of ulcerative colitis.

Gray FL, Turner CG, Zurakowski D, Bousvaros A, Linden BC, Shamberger RC, Lillehei CW.

J Pediatr Surg. 2013 Jul;48(7):1540-5. doi: 10.1016/j.jpedsurg.2013.03.006.

PMID:
23895969
35.

Targeted quantitative amniotic cell profiling: a potential diagnostic tool in the prenatal management of neural tube defects.

Pennington EC, Gray FL, Ahmed A, Zurakowski D, Fauza DO.

J Pediatr Surg. 2013 Jun;48(6):1205-10. doi: 10.1016/j.jpedsurg.2013.03.009.

PMID:
23845608
36.

Monoamine transporter occupancy of a novel triple reuptake inhibitor in baboons and humans using positron emission tomography.

Comley RA, Salinas CA, Slifstein M, Petrone M, Marzano C, Bennacef I, Shotbolt P, Van der Aart J, Neve M, Iavarone L, Gomeni R, Laruelle M, Gray FA, Gunn RN, Rabiner EA.

J Pharmacol Exp Ther. 2013 Aug;346(2):311-7. doi: 10.1124/jpet.112.202895. Epub 2013 May 17.

PMID:
23685546
37.

Intra-amniotic delivery of amniotic-derived neural stem cells in a syngeneic model of spina bifida.

Turner CG, Pennington EC, Gray FL, Ahmed A, Teng YD, Fauza DO.

Fetal Diagn Ther. 2013;34(1):38-43. doi: 10.1159/000350267. Epub 2013 Apr 26.

PMID:
23635813
38.

CD8 encephalitis in HIV-infected patients receiving cART: a treatable entity.

Lescure FX, Moulignier A, Savatovsky J, Amiel C, Carcelain G, Molina JM, Gallien S, Pacanovski J, Pialoux G, Adle-Biassette H, Gray F.

Clin Infect Dis. 2013 Jul;57(1):101-8. doi: 10.1093/cid/cit175. Epub 2013 Mar 20.

PMID:
23515205
39.

Exploring role confusion in nurse case management.

Gray FC, White A, Brooks-Buck J.

Prof Case Manag. 2013 Mar-Apr;18(2):66-76; quiz 77-8. doi: 10.1097/NCM.0b013e31827a4832.

PMID:
23389706
40.

Measurement of muon capture on the proton to 1% precision and determination of the pseudoscalar coupling gP.

Andreev VA, Banks TI, Carey RM, Case TA, Clayton SM, Crowe KM, Deutsch J, Egger J, Freedman SJ, Ganzha VA, Gorringe T, Gray FE, Hertzog DW, Hildebrandt M, Kammel P, Kiburg B, Knaack S, Kravtsov PA, Krivshich AG, Lauss B, Lynch KR, Maev EM, Maev OE, Mulhauser F, Petitjean C, Petrov GE, Prieels R, Schapkin GN, Semenchuk GG, Soroka MA, Tishchenko V, Vasilyev AA, Vorobyov AA, Vznuzdaev ME, Winter P; MuCap Collaboration.

Phys Rev Lett. 2013 Jan 4;110(1):012504. Epub 2013 Jan 3.

PMID:
23383785
41.

Encephalitis with infiltration by CD8+ lymphocytes in HIV patients receiving combination antiretroviral treatment.

Gray F, Lescure FX, Adle-Biassette H, Polivka M, Gallien S, Pialoux G, Moulignier A.

Brain Pathol. 2013 Sep;23(5):525-33. doi: 10.1111/bpa.12038. Epub 2013 Mar 18.

PMID:
23347174
42.

Business case for Magnet® in a small hospital.

Higdon K, Clickner D, Gray F, Woody G, Shirey M.

J Nurs Adm. 2013 Feb;43(2):113-8. doi: 10.1097/NNA.0b013e31827f2208.

PMID:
23343728
43.

A novel hereditary extensive vascular leukoencephalopathy mapping to chromosome 20q13.

Hervé D, Chabriat H, Rigal M, Dalloz MA, Kawkabani Marchini A, De Lepeleire J, Fontaine B, Ceuterick-de Groote C, Alili N, Mine M, Delaforge A, Bousser MG, Guichard JP, Martin JJ, Gray F, Tournier-Lasserve E.

Neurology. 2012 Dec 4;79(23):2283-7. doi: 10.1212/WNL.0b013e3182768954. Epub 2012 Nov 21.

PMID:
23175731
44.

Pharmacokinetics and central nervous system effects of the novel dual NK1 /NK3 receptor antagonist GSK1144814 in alcohol-intoxicated volunteers.

te Beek ET, Hay JL, Bullman JN, Burgess C, Nahon KJ, Klaassen ES, Gray FA, van Gerven JM.

Br J Clin Pharmacol. 2013 May;75(5):1328-39. doi: 10.1111/bcp.12004.

45.

Detection of disordered regions in globular proteins using ¹³C-detected NMR.

Gray FL, Murai MJ, Grembecka J, Cierpicki T.

Protein Sci. 2012 Dec;21(12):1954-60. doi: 10.1002/pro.2174.

46.

Socio-Environmental Health Analysis in Nogales, Sonora, Mexico.

Norman LM, Caldeira F, Callegary J, Gray F, O' Rourke MK, Meranza V, Van Rijn S.

Water Qual Expo Health. 2012 Jun;4(2):79-91. Epub 2012 Apr 12.

47.

Prenatal tracheal reconstruction with a hybrid amniotic mesenchymal stem cells-engineered construct derived from decellularized airway.

Gray FL, Turner CG, Ahmed A, Calvert CE, Zurakowski D, Fauza DO.

J Pediatr Surg. 2012 Jun;47(6):1072-9. doi: 10.1016/j.jpedsurg.2012.03.006.

PMID:
22703772
48.

Craniofacial repair with fetal bone grafts engineered from amniotic mesenchymal stem cells.

Turner CG, Klein JD, Gray FL, Ahmed A, Zurakowski D, Fauza DO.

J Surg Res. 2012 Dec;178(2):785-90. doi: 10.1016/j.jss.2012.05.017. Epub 2012 May 22.

PMID:
22656041
49.

Impact of hyperglycemia on neuropathological alterations during critical illness.

Sonneville R, den Hertog HM, Güiza F, Gunst J, Derese I, Wouters PJ, Brouland JP, Polito A, Gray F, Chrétien F, Charlier P, Annane D, Sharshar T, Van den Berghe G, Vanhorebeek I.

J Clin Endocrinol Metab. 2012 Jun;97(6):2113-23. doi: 10.1210/jc.2011-2971. Epub 2012 Mar 22.

PMID:
22442271
50.

Concept analysis: case management role confusion.

Gray FC, White A.

Nurs Forum. 2012 Jan-Mar;47(1):3-8. doi: 10.1111/j.1744-6198.2011.00244.x.

PMID:
22309376

Supplemental Content

Support Center